Overview for AACR Special Conference in Cancer Research: Functional and Genomic Precision Medicine in Cancer: Different Perspectives, Common Goals
Efficacy findings from a phase 2 trial demonstrated that abenacianine visualized lung tumor tissue and was well tolerated when used during surgery.
The prevalence of metabolic syndrome among adult survivors of childhood cancer is higher compared to a noncancer control population. Therapeutic exposures and lifestyle factors are…
Study results “provide strong support for integrating symptom screening and care pathways into routine clinical care,” according to researchers
Click on the article title to read more.
The BBC’s Analysis editor, Ros Atkins, investigates Elon Musk’s recent posts on X about grooming gangs – and looks at how one day unfolded on…
Abstract. Over the past decade, T-cell–directed therapies, including chimeric antigen receptor T-cell (CAR-T) and bispecific T-cell engager (BTE) therapies
Christopher Graham, MD, details how axatilimab has changed the care of cGVHD and highlights considerations with axatilimab, belumosudil, and ruxolitinib.
TYRA-300 has gained an investigational new drug application from the FDA and will be further studied in the phase 2 SURF302 trial for patients with…
Rectal cancer recurrence after prior radiotherapy presents a difficult treatment challenge. Salvage treatment can be curative, however, it often requires multimodal therapy which can come…
